TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
STOK

Stoke Therapeutics Inc

Healthcare · Biotechnology

26.00$ +0.5% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Stoke Therapeutics Inc (STOK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 394 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet STOK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
240 228 205 308 293 272 407 385 360 418 443 394
230 215 193 297 254 233 376 270 272 306 367 323
190 191 179 193 150 128 275 101 83 84 156 110
215 201 179 282 239 217 357 248 248 285 344 293
0.1 0.1 0.0 0.3 0.7 0.7 0.6 1.6 11 7.9 6.1 8.7
11 – – – 0.1 – – – – – – –
9.3 – – – – – – – – – – –
67 69 65 65 61 43 57 50 52 66 48 48
25 31 36 44 50 40 45 39 42 58 41 42
2.5 2.1 2.2 2.3 2.3 2.3 2.4 2.3 2.9 3.0 2.4 1.8
3.1 1.7 2.1 3.9 2.5 2.5 2.2 4.3 5.9 4.9 6.8 4.8
173 160 140 243 232 229 350 335 308 352 395 346
-375 -402 -428 -454 -480 -491 -378 -401 -440 -498 -548 -609
44 45 46 56 56 57 59 58 59 58 63 66

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?